[go: up one dir, main page]

MXPA06000712A - Composicion farmaceutica orodispersable de un compuesto antitrombotico. - Google Patents

Composicion farmaceutica orodispersable de un compuesto antitrombotico.

Info

Publication number
MXPA06000712A
MXPA06000712A MXPA06000712A MXPA06000712A MXPA06000712A MX PA06000712 A MXPA06000712 A MX PA06000712A MX PA06000712 A MXPA06000712 A MX PA06000712A MX PA06000712 A MXPA06000712 A MX PA06000712A MX PA06000712 A MXPA06000712 A MX PA06000712A
Authority
MX
Mexico
Prior art keywords
compound
pharmaceutical composition
orodispersable
antitrombotic
fecula
Prior art date
Application number
MXPA06000712A
Other languages
English (en)
Inventor
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MXPA06000712A publication Critical patent/MXPA06000712A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se refiere a una composicion farmaceutica solida orodispersable de un compuesto antitrombotico (compuesto A), que se caracteriza en que contiene el compuesto A o una de las sales farmaceuticamente aceptables del mismo, y granulos que consisten de lactosa y fecula secadas juntas.
MXPA06000712A 2003-07-18 2004-07-16 Composicion farmaceutica orodispersable de un compuesto antitrombotico. MXPA06000712A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308780A FR2857593B1 (fr) 2003-07-18 2003-07-18 Composition pharmaceutique orodispersible d'un compose antithrombotique
PCT/FR2004/001866 WO2005009428A2 (fr) 2003-07-18 2004-07-16 Composition pharmaceutique orodispersible d'un compose antithrombotique

Publications (1)

Publication Number Publication Date
MXPA06000712A true MXPA06000712A (es) 2006-04-11

Family

ID=33548240

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000712A MXPA06000712A (es) 2003-07-18 2004-07-16 Composicion farmaceutica orodispersable de un compuesto antitrombotico.

Country Status (27)

Country Link
US (1) US20060167100A1 (es)
EP (1) EP1646373B1 (es)
JP (1) JP2006528160A (es)
KR (1) KR100762598B1 (es)
CN (1) CN100544709C (es)
AR (1) AR045724A1 (es)
AT (1) ATE409032T1 (es)
AU (1) AU2004258713B2 (es)
BR (1) BRPI0412706A (es)
CA (1) CA2532608A1 (es)
DE (1) DE602004016751D1 (es)
DK (1) DK1646373T3 (es)
EA (1) EA010372B1 (es)
ES (1) ES2314440T3 (es)
FR (1) FR2857593B1 (es)
GE (1) GEP20094649B (es)
HR (1) HRP20080521T3 (es)
MA (1) MA27891A1 (es)
MX (1) MXPA06000712A (es)
MY (1) MY138799A (es)
NO (1) NO20060803L (es)
PL (1) PL1646373T3 (es)
PT (1) PT1646373E (es)
SI (1) SI1646373T1 (es)
UA (1) UA79567C2 (es)
WO (1) WO2005009428A2 (es)
ZA (1) ZA200600241B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2899473B1 (fr) * 2006-04-07 2008-06-13 Servier Lab Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires
CN101668692B (zh) 2007-05-11 2012-07-11 奥蒂斯电梯公司 具有基于所需服役寿命的初始安全系数的电梯承载组件
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
US8307129B2 (en) * 2008-01-14 2012-11-06 International Business Machines Corporation Methods and computer program products for swapping synchronous replication secondaries from a subchannel set other than zero to subchannel set zero using dynamic I/O
US7761610B2 (en) * 2008-01-25 2010-07-20 International Business Machines Corporation Methods and computer program products for defining synchronous replication devices in a subchannel set other than subchannel set zero
US8516173B2 (en) * 2008-07-28 2013-08-20 International Business Machines Corporation Swapping PPRC secondaries from a subchannel set other than zero to subchannel set zero using control block field manipulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6171616B1 (en) * 1998-04-13 2001-01-09 Shin-Etsu Chemical Co., Ltd. Solid preparation and a method of manufacturing it
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
KR200250082Y1 (ko) * 2001-05-15 2001-11-16 포스텍전자주식회사 힌지 유니트

Also Published As

Publication number Publication date
EP1646373A2 (fr) 2006-04-19
BRPI0412706A (pt) 2006-09-26
SI1646373T1 (sl) 2009-02-28
WO2005009428A3 (fr) 2005-04-07
EA010372B1 (ru) 2008-08-29
US20060167100A1 (en) 2006-07-27
ZA200600241B (en) 2007-04-25
CA2532608A1 (fr) 2005-02-03
PL1646373T3 (pl) 2009-02-27
HK1094152A1 (zh) 2007-03-23
WO2005009428A2 (fr) 2005-02-03
JP2006528160A (ja) 2006-12-14
AR045724A1 (es) 2005-11-09
KR100762598B1 (ko) 2007-10-04
EA200600173A1 (ru) 2006-08-25
DE602004016751D1 (de) 2008-11-06
HRP20080521T3 (hr) 2009-01-31
FR2857593A1 (fr) 2005-01-21
ES2314440T3 (es) 2009-03-16
CN1819823A (zh) 2006-08-16
FR2857593B1 (fr) 2005-10-14
NO20060803L (no) 2006-02-17
KR20060031688A (ko) 2006-04-12
MY138799A (en) 2009-07-31
UA79567C2 (en) 2007-06-25
MA27891A1 (fr) 2006-05-02
EP1646373B1 (fr) 2008-09-24
CN100544709C (zh) 2009-09-30
DK1646373T3 (da) 2008-12-15
PT1646373E (pt) 2008-11-13
AU2004258713A1 (en) 2005-02-03
ATE409032T1 (de) 2008-10-15
GEP20094649B (en) 2009-03-25
AU2004258713B2 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
GT200400239A (es) Procedimiento para la preparacion de una composicion farmaceutica solida administrable oralmente
CR9353A (es) Una formulacion solida de dosificacion farmaceutica
DE60334678D1 (de) Antikörper enthaltende pharmazeutische lösungen
ECSP045429A (es) Combinacion de compuestos organicos
UY28138A1 (es) Intermedio de formulación aceptablemente no higroscópico que comprende un fármaco higroscópico
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
NO20024891D0 (no) Farmasöytiske sammensetninger
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
HRP20090498T1 (hr) Kombinacija r,r-glikopirolata, roliprama i budesonida za liječenje upalnih oboljenja
ECSP044981A (es) Composicion oftalmica que comprende ascomicina
PA8583501A1 (es) Derivados de pirrolidona como inhibidores de maob
PA8579801A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
ATE330017T1 (de) Kallikrein gen
ATE474561T1 (de) Orodispersible pharmazeutische zusammensetzung für die orale, oromukosale oder sublinguale verabreichung von agomelatin
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
DK1532124T3 (da) Anvendelse af nitriderivater som medikament
WO2003105751A3 (en) Novel curcumin derivatives
MXPA06000712A (es) Composicion farmaceutica orodispersable de un compuesto antitrombotico.
BRPI0408299A (pt) inibidores de catepsina s
PA8691901A1 (es) Composicion farmaceutica solida que comprende 1-(4-cloro-anilino)-4-(4-piridil-metil)-ftalazina y un modificador del ph
MX2008001597A (es) Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento.
BRPI0417265A (pt) composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
BRPI0407850A (pt) processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados
DE50309647D1 (de) Ng fibrotischer erkrankungen

Legal Events

Date Code Title Description
FG Grant or registration